Tiangang Yinuo
Hefei
About Tiangang Yinuo
Tiangang Yinuo is a company that specializes in the creation of novel immunological medications that employ the body's own immune system to combat cancers, viral infections, and other disorders, as well as NK cell research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Nov 2024)
- Website: cn.tgimmunopharma.com
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/tiangang-yinuo-3433793 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.